Home
Categories
Send inquiry
Home
ENTER LIZHUO
Company Profile
Company Culture
R&D
Factory Profile
Products
Pharmaceutical Intermediate
Anti-tumor intermediate
Precious Metal Catalyst
Ruthenium catalyst
Custom Service
Custom Synthesis
Synthesis Strength
Quality Assurance
News
Join Us
Talent demand and training
Contact Us
Home
ENTER LIZHUO
Company Profile
Company Culture
R&D
Factory Profile
Products
Pharmaceutical Intermediate
Anti-tumor intermediate
Precious Metal Catalyst
Ruthenium catalyst
Custom Service
Custom Synthesis
Synthesis Strength
Quality Assurance
News
Join Us
Talent demand and training
Contact Us
Featured
Home
News
News
The world’s first oral SERD has been approved, adding another member to the advanced breast cancer killer!
Breast cancer endocrine therapy is an important means of treatment of hormone receptor positive breast cancer. The main cause of drug resistance in HR+ patients after receiving first-line therapy (tamoxifen TAM or aromatase inhibitor AI) is mutations in the estrogen receptor gene α (ESR1). Patien...
Read More
The market price of raw materials has risen significantly, and the market demand for some raw materials has rebounded
Raw material drug refers to the raw material drug used in the production of various preparations, which is the active ingredient in the preparation, various powders, crystals, extracts, etc. used for medicinal purposes prepared by chemical synthesis, plant extraction or biotechnology, but A subst...
Read More
Insufficient self-sufficiency of raw materials in Japan
Active Pharmaceutical Ingredients (APIs) play a key role in the pharmaceutical industry and are the primary basis for the manufacture of all pharmaceuticals. The market size of the Japanese pharmaceutical industry ranks second in Asia. With the increase in R&D expenditure of the pharmaceutica...
Read More